<table id="ID234" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>TABLE 3. Average Pharmacokinetic Parameters of Ceftriaxone in Pediatric Patients With Meningitis</caption>
<col span="1" width="49%"></col>
<col span="1" width="24%"></col>
<col span="1" width="27%"></col>
<tbody>
<tr>
<td>
<br/>
</td>
<td>50 mg/kg IV<br/>
</td>
<td>75 mg/kg IV<br/>
</td>
</tr>
<tr>
<td>Maximum Plasma Concentrations (mcg/mL)<br/>
</td>
<td>216<br/>
</td>
<td>275<br/>
</td>
</tr>
<tr>
<td>Elimination Half-life (hr)<br/>
</td>
<td>4.6<br/>
</td>
<td>4.3<br/>
</td>
</tr>
<tr>
<td>Plasma Clearance (mL/hr/kg)<br/>
</td>
<td>49<br/>
</td>
<td>60<br/>
</td>
</tr>
<tr>
<td>Volume of Distribution (mL/kg)<br/>
</td>
<td>338<br/>
</td>
<td>373<br/>
</td>
</tr>
<tr>
<td>CSF Concentration-inflamed meninges (mcg/mL)<br/>
</td>
<td>5.6<br/>
</td>
<td>6.4<br/>
</td>
</tr>
<tr>
<td>Range (mcg/mL)<br/>
</td>
<td>1.3-18.5<br/>
</td>
<td>1.3-44<br/>
</td>
</tr>
<tr>
<td>Time after dose (hr)<br/>
</td>
<td>3.7 (±1.6)<br/>
</td>
<td>3.3 (±1.4)<br/>
</td>
</tr>
</tbody>
</table>